Skip to content
  • Friday, 14 August 2026
  • 10:21 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.
Clinical Diagnostics & Pathology

Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.

Reynand Amr Wu Apr 7, 2026 0

A federal jury in Dallas has delivered a resounding verdict, convicting Texas laboratory owner and former NFL player Keith J.…

Read More
Clinical Diagnostics & Pathology

Walk-in Lab Testing in West Virginia Accelerates Consumer-Driven Healthcare, Reshaping Diagnostic Access and Clinical Lab Models

Reynand Amr Wu Apr 3, 2026 0

The landscape of healthcare diagnostics is undergoing a profound transformation, with walk-in lab testing emerging as a pivotal force in…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu Apr 1, 2026 0

The World Health Organization (WHO) has unveiled a set of groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, emphasizing…

Read More
Stem Cell & Regenerative Medicine

University of Basel Researchers Replicate Human Bone Marrow in Landmark Study to Advance Blood Cancer Research and Reduce Animal Testing

Dwi Wanna Mar 30, 2026 0

In a significant breakthrough for regenerative medicine and oncology, researchers at the University of Basel and University Hospital Basel have…

Read More
Clinical Diagnostics & Pathology

Keith J. Gray’s conviction underscores rising enforcement and audit risk as Medicare spending shifts toward high-cost genetic testing.

Reynand Amr Wu Mar 30, 2026 0

A federal jury in Dallas has delivered a decisive verdict against Keith J. Gray, a 39-year-old Texas laboratory owner and…

Read More
Clinical Diagnostics & Pathology

CMS Launches Sweeping Anti-Fraud Initiative, Targeting Genetic Testing Spending and Soliciting Lab Industry Input for Future Regulations

Reynand Amr Wu Mar 26, 2026 0

The Centers for Medicare and Medicaid Services (CMS) has embarked on a significant preemptive strike against healthcare fraud, initiating a…

Read More
Clinical Diagnostics & Pathology

Ex-NFL Player Convicted in $328M Genetic Testing Fraud as Medicare Scrutiny Intensifies

Reynand Amr Wu Mar 23, 2026 0

A federal jury in Dallas has delivered a resounding verdict against Keith J. Gray, a 39-year-old Texas laboratory owner and…

Read More
Clinical Diagnostics & Pathology

Donor-Derived Cell-Free DNA Testing Revolutionizes Post-Transplant Surveillance, Offering Early Organ Injury Detection and Reducing Invasive Biopsies

Reynand Amr Wu Mar 19, 2026 0

A groundbreaking blood test measuring donor-derived cell-free DNA (dd-cfDNA) is fundamentally transforming post-transplant patient management, providing clinical laboratories with an…

Read More
Stem Cell & Regenerative Medicine

Researchers Create First Fully Human 3D Bone Marrow Model to Advance Cancer Treatment and Reduce Animal Testing

Dwi Wanna Mar 14, 2026 0

In a landmark development for regenerative medicine and oncology, scientists at the University of Basel and University Hospital Basel have…

Read More

Posts pagination

1 … 5 6
Toward autonomous, self-organizing biological robots with a nervous systemThe biotech bi-weekly: genome editing, life-extending therapeutics, an early-stage biotech hub and moreHKUMed Researchers Identify Piezo1 Protein as the Key Exercise Sensor in Bone Maintenance and Potential Target for Osteoporosis TreatmentHow ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ